Join the Oncology Voice Network. Join for Free
Be Brave-A Networking Tale that Led to Friendship
authentic networking LinkedIn connections overcoming networking fear building genuine connections networking communication skills altruism in networking networking courage

Be Brave-A Networking Tale that Led to Friendship


Share This Article


Summary

In this episode, Josh Yoder and Kirsten Borbe to share their amazing story of how a networking message on LinkedIn led to a friendship. The discussion begins with insights into Josh and Kirsten's backgrounds and networking perspectives. They emphasize the importance of authentic networking and overcoming fear, sharing strategies for building genuine connections and evolving professional relationships into friendships. Key communication skills such as brevity and authenticity are highlighted, alongside the role of altruism in networking. The conversation addresses the fear of risk and concludes with thoughts on networking courage and bravery. Closing remarks offer appreciation for the insights shared.

Key Points

  • Networking should be approached with authenticity and a genuine interest in others, rather than self-promotion.
  • Building meaningful connections often involves taking risks and embracing opportunities, even if it means stepping out of your comfort zone.
  • The real value in networking comes from helping others without expecting anything in return, which often leads to more fulfilling and long-lasting relationships.

Click for Source
authentic networking, LinkedIn connections, overcoming networking fear, building genuine connections, networking communication skills, altruism in networking, networking courage

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Article
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Explore OVN